Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF (588700.SS) Price
Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF Price
Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF List of Holdings
Frequently asked questions about Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF
Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF is offered by Harvest, a leading player in the field of passive investments.
The ISIN of Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF is CNE100006BP8.
The total expense ratio of Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF is 0.60%, which means that investors pay 60.00 CNY per 10,000 CNY in investment capital annually.
The ETF is listed in CNY.
European investors may incur additional costs for currency exchange and transaction fees.
No, Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF does not comply with the EU UCITS investor protection directives.
Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF tracks the performance of the SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Net.
Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF is domiciled in CN.
The fund was launched on 12/27/2023.
The Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF mainly invests in Healthcare companies.
The NAV of Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF amounts to 1.05 M CNY.
Investments can be made through brokers or financial institutions that provide access to trading ETFs.
The ETF is traded on the stock exchange, similar to stocks.
Yes, the ETF can be held in a regular securities account.
The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.
The ETF is valued on a daily stock exchange basis.
Information on dividends should be requested from the provider's website or your broker.
The risks include market fluctuations, currency risks, and the risk associated with smaller companies.
The ETF is obligated to report regularly and transparently on its investments.
The performance can be viewed on Eulerpool or directly on the provider's website.
Further information can be found on the official website of the provider.
ETF profile
Harvest SSE Science and Technology Innovation Board Biopharmaceutical ETF